Various neurological complications have been described in patients with coeliac disease. These include: peripheral neuropathy, myopathy, myelopathy, cerebellar syndrome, and encephalomyeloradiculopathy.1 2 Case report A 54 year old Irish woman first presented to her local hospital in 1970 with a two year history of abdominal pain; pale, watery stools; ankle swelling and weight loss. Blood tests revealed iron, folic acid and vitamin K deficiency, and low levels of serum albumin and calcium. A peroral suction biopsy of the third part of the duodenum showed partial villous atrophy, flattening of surface enterocytes, increased epithelial lymphocytes, and increased mononuclear cell infiltration in the lamina propria suggesting adult coeliac disease. A gluten free diet was instituted and the diet supplemented with iron, folic acid, calcium, and vitamin B12. Within weeks, her pain and diarrhoea had disappeared, and her weight, haematological and biochemical abnormalities had returned to normal. The jejunal morphology was not, however, reassessed. She continued to enjoy good health until seven years later when, after a three month period of anorexia and weight loss, she developed deafness in the right ear, numbness on the right side of the face, an absent right corneal reflex, and some unsteadiness of gait. The clinical features suggested a lesion in the region of the right cerebellopontine angle or affecting the right side of the brain stem. Full radiological studies of the skull (including CT scan and vertebral and carotid angiograms) were noncontributory.
Over the next six months, the lower limbs became progressively weaker. Examination revealed that the cranial nerve signs had receded somewhat but there was now weakness of both lower limbs. Tendon reflexes and perception of pinprick were absent below the knees. The plantar responses were equivocal, possibly extensor. The visual evoked responses were normal, as was the spinal fluid. The haemoglobin was 14-2 g/dl, albumin 40 g/l, calcium 2.45 mmol/l, red cell folate 64 ng/ml (normal 160-640), and urine D-xylose excretion after five hours was (Table) and for the first time, there was evidence of hyposplenism on the blood film (Howell-Jolly bodies). Splenic hypofunction was confirmed by showing reduced clearance of 51Cr labelled heat-damaged erythrocytes. Furthermore, the serum iron level, D-xylose, and vitamin B12 absorption continued to fall (Table) . Over the same four month period, serial neurological examinations by an individual observer (CAP) and myometric analyses (Fig. 2) confirmed progressive deterioration. In view of the suspicion of a malignancy complicating coeliac disease, bone marrow examination and a barium series were performed, but revealed no abnormalities. She was therefore subjected to elective laparo- tomy at which no evidence of malignancy was found macroscopically or on biopsies of the intestine and liver. Four weeks postoperatively, she developed ankle swelling, deterioration of the weakness and wasting in the lower limbs, and general lethargy. The haemoglobin level had fallen to 9.4 g/dl and the albumin to 24 g/l, and both the total leucocyte and platelet counts were falling rapidly. A repeat bone marrow biopsy revealed hypercellular fragments consisting predominantly of malignant histiocytes (Fig. 3) . The histiocytic nature of the cells was supported by positive immunocytochemical staining for muramidase and (xl-antitrypsin.
Treatment was begun with cyclophosphamide, vinblastine, adriamycin, and prednisolone in conventional dosage and, within two weeks of the first course of treatment, there was an improvement in her general condition and nutritional status (Hb 14 g/dl, cholesterol 5-8 mmol/l, albumin 42 g/l). Dxylose (33 mmol (5 g) excreted in five hours, after 25 g load) and B12 absorption (Schilling test with intrinsic factor 17% excretion in 24 hours) returned to normal and the jejunal mucosa (Fig. 4) showed taller villi, less crypt hyperplasia, and reduced mononuclear cell infiltration. A trephine marrow biopsy was hypocellular and no malignant histiocytes were detected.
At this stage, further examination of the cerebrospinal fluid revealed histiocytes, the malignant nature of which was uncertain. In view of the possibility of malignant infiltration of the meninges, however, she was treated with intrathecal methotrexate. As shown by myometric testing, there was a marked improvement in the power in both lower limbs after the first cycle of systemic and intrathecal chemotherapy.
Despite this promising initial response to the first Fig. 3 Necropsy revealed malignant histiocytosis in the bone marrow (confirmed immunohistochemically using antimuramidase and stains for a1-antitrypsin).
Although occasional histiocytes with somewhat atypical morphology were present in other organs (lymph nodes, liver), no definite evidence of involvement of these organs by malignant histiocytosis was found.
The intestinal epithelium was autolysed; however, well-formed villi were recognisable, suggesting recovery from the villous atrophy existing before treatment with cytotoxic chemotherapy. There was no evidence of malignant histiocytosis in a large number of sections taken from various levels of the intestine. Failure to identify infiltration by malignant histiocytes in the viscera usually affected (small intestine, liver, and lymph nodes) may have been because of the cytotoxic agents administered.
The central and peripheral nervous system also showed no evidence of histiocytosis at postmortem examination. There was, however, a small area of myelin loss in the brain stem in the pattern seen with central pontine myelinolysis (Fig. 5) . The spinal cord showed dorsal column pallor (demyelination with some axonal degeneration) which was most marked in the lumbar segments (Fig. 6 ).
Discussion
The initial diagnosis of coeliac disease in this patient was based on the clinical picture, histological assessment consistent with this diagnosis and a prompt clinical, haematological, and biochemical response to a gluten free diet. As follow-up biopsies were not performed, however, no clear histological response to gluten restriction was shown and compliance with a gluten free diet was not rigorous over the 10 year period between the initial presentation and first development of neurological symptoms.
The neurological condition was characterised by evidence of discrete lesions dispersed in the central nervous system, with involvement of the postchiasmatic optic tracks, brain stem at the level of the cochlear nucleus, the posterior columns in the spinal cord, and the lumbosacral roots. The presence of an oligoclonal pattern in the CSF, with prolonged visual evoked responses and multiple lesions suggested a diagnosis of multiple sclerosis. The size of the brain stem lesion and the evidence of radicular involvement, however, were more consistent with a diagnosis of encephalomyeloradiculopathy complicating coeliac disease.
Cooke and Smith6 reported 16 patients with biopsy-proven coeliac disease who developed a picture characterised by sensory ataxia with loss of all modalities of sensation, associated in some patients with cerebellar signs and unexplained episodes of unconsciousness. Fourteen patients developed the neurological complication while on a gluten free diet and 10 patients suffered progressive deterioration. Necropsy in nine -patients showed tract degeneration (posterior and lateral columns of the spinal cord) in the majority and focal demyelination, cerebellar cortical degeneration, and vasculartype lesions in occasional cases. The aetiology of these complications was not determined; only one of Cooke and Smith's patients was deficient in vitamin B12; no patients responded to B12 therapy; however, five recovered while receiving high dose parenteral supplementation of water soluble vitamins. This was the basis for the therapeutic trial attempted in our patient, albeit without success.
In our patient the main necropsy findings in the central nervous system were posterior column degeneration, and focal brain stem myelin loss resembling a small area of central pontine myelinolysis. The former is consistent with the experience of Cooke and Smith while the latter finding may be seen as a terminal event in desperately ill patients where maintaining adequate nutritional support is difficult. 7 An increased incidence of lymphoma is well recognised in patients with coeliac disease.8 9 In a recent report3 27 out of 385 patients with coeliac disease developed lymphoma: in 23 of these patients the histological type was described as reticulum cell sarcoma. In a series of 18 patients with malabsorption associated with small intestinal lymphoma reported by Isaacson and Wright,5 the cell type was believed to be histiocytic in all and recently an MRC co-ordinated study of malignancy in coeliac disease10 confirmed that the lymphoma should be preferably classified as a malignant histiocytosis.
Using strict morphological and immunohistochemical criteria, the lymphoma in the patient described here was classified as malignant histio- cytosis. It is intriguing to note that one of the patients reported by Isaacson and Wright5 had suffered from malabsorption, thought to be because of coeliac disease, for nine years before malignant histiocytosis was diagnosed. Although it is generally accepted that coeliac disease may be complicated by malignant histiocytosis, there are few reported cases of overtly life-long coeliac disease with this complication, most patients presenting with a malignancy or developing one within a few years of the diagnosis of coeliac disease in middle-age. It seems possible that this condition is distinct from childhood coeliac disease and represents a histiocytic disorder affecting the gut with a long latency before malignant proliferation is evident. In this case the role of gluten sensitivity may be secondary. Clarification of this problem requires the demonstration of a clear morphological response to a gluten free diet in individuals who subsequently and at a much later date, develop malignant histiocytosis. This case does not fulfill these criteria.
Although bone marrow infiltration in patients with malignant histiocytosis of the intestine is not uncommon (five out of 18 in Isaacson and Wright's series5), involvement of the central nervous system is unusual. A patient with histiocytic lymphoma of the small intestine complicating coeliac disease11 later developed a histiocytic tumour in the right parietotemporal region.12 Another patient reported from the Massachusetts General Hospital showed many similarities to the patient reported here. 13 This was a 50 year old man who had suffered from coeliac disease for 10 years when (while apparently in remission) he developed sensory ataxia with loss of posterior column sensation. Four years later, in a preterminal illness, he developed head and neck ache, cerebellar signs and haematemesis. Postmortem examination revealed reticulum cell sarcoma (a term probably synonymous with malignant histiocytosis) at various sites in small and large intestine, liver, spleen, lymph nodes, leptomeninges, and spinal roots. There was also old demyelination of the posterior columns of the spinal cord (which was considered responsible for the neurological picture that developed four years before his death). The small intestine showed many features consistent with a diagnosis of coeliac disease. Interestingly, one of the 16 patients with encephalomyeloradiculopathy originally described by Cooke and Smith6 was found to have a multifocal histiocytic tumour (called reticulum cell sarcoma) of the small intestine. There was no evidence, however, of malignant infiltration of the nervous system.
It was conceivable that the progressive neurological deterioration in the final year of the patient's illness may have been because of central nervous system infiltration. The cytological characteristics of the histiocytes found in the CSF, however, did not suggest malignancy though the patient had received intrathecal methotrexate. Postmortem examination did not reveal malignant infiltration of neural tissue or nerve roots. It remains possible that the neurological deterioration was because of a paraneoplastic phenomenon, though it is doubtful if this occurs in patients with histiocytic malignancies. 14 An unrecognised nutritional deficiency (cf. ref 15) may also be postulated.
A study of the biochemical parameters measured serially in this patient's illness revealed parallel changes in the haemoglobin, albumin, and total cholesterol levels. The progressive and dramatic fall in the total serum cholesterol level (to 1.5 mmol/l) has not been reported previously in such patients, and we have not observed this phenomenon in coeliac disease complicated by intestinal adenocarcinoma. One intriguing possibility is that the cholesterol was being sequestered by the malignant histiocytes. Lampert, Catovsky, and Bergier16 reported low plasma cholesterol levels in six of their 12 patients with histiocytic medullary reticulosis.
Although there was no improvement in gut morphology and function over several months of strict gluten exclusion, a striking improvement in jejunal morphology and intestinal function occurred with eight days of the first course of cytotoxic therapy. This kind of improvement in villous morphology may be seen in uncomplicated coeliac disease treated with a gluten free diet but in our experience usually takes a minimum of two or three months and often longer. There are no reports of the use of cytotoxic or immunosuppressant combination chemotherapy in uncomplicated coeliac disease for obvious reasons but it is interesting to speculate that the delayed morphological response characteristically seen after gluten withdrawal may be because of persisting immunological mechanisms directed against the gut. The alternative explanation is that the intestinal lesion in patients with malignant histiocytosis is a response to the malignancy per se and not to gluten hypersensitivity and responds accordingly to chemotherapy and tumour regression. 
